TransCode Therapeutics (RNAZ) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-56
-37.53
-19.05
-0.58

Details

Expected EPS
-8.68
Actual EPS
N/A
Surprise EPS
8.68
Surprise Percent
+100%

Description

TransCode Therapeutics (RNAZ) will report earnings of for Q3 2025 on August 14, 2025.

0 Comments

Share your thoughts